I have high hopes for the anti PD-1 class not only from the scientific point of view but also since a friend has been enrolled to the CureTech/CT-011 phase II metastatic melanoma clinical trial.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.